Stratasys Ltd. reported fourth‑quarter 2025 revenue of $140.0 million, a modest $0.7 million (0.5%) above the consensus estimate of $139.3 million, while the company missed higher estimates that ranged up to $142.56 million. Non‑GAAP earnings per share came in at $0.07, beating the consensus of $0.06 by $0.01 (16.7%) and exceeding the lower estimate of $0.05 by $0.02. The quarter ended with a GAAP net loss of $18.9 million, or $0.22 per diluted share, underscoring the company’s ongoing profitability challenges.
Revenue growth was driven by a 2.4% year‑over‑year increase in consumables sales, offset by a decline in system sales and a drop in service revenue. The mix shift toward consumables and services—segments that typically carry higher margins—helped cushion the revenue dip, but the overall decline in system demand weighed on top‑line performance.
Gross‑margin compression was evident: GAAP gross margin fell to 36.8% from 46.3% in Q4 2024, while Non‑GAAP gross margin slipped to 46.3% from 49.6%. The decline reflects a combination of restructuring charges, tariff impacts, and a less favorable product mix, all of which eroded profitability despite the company’s efforts to control costs.
Management guidance for 2026 signals caution. The company forecasts full‑year revenue of $565 million to $575 million, unchanged from prior guidance, but it projects Non‑GAAP EPS of $0.09 to $0.14—well below the consensus expectation of approximately $0.24. This conservative outlook indicates management’s concern about near‑term demand softness, margin pressure, and the need to preserve cash.
CEO Dr. Yoav Zeif highlighted operational discipline and solid cash‑flow generation, noting that manufacturing‑application revenue grew to 37.5% of total sales in 2025, up from 25% in 2020. CFO Eitan Zamir projected 2026 Non‑GAAP gross margins of 46.7% to 47.1%, acknowledging the continued impact of tariffs and foreign‑exchange fluctuations.
Investors reacted negatively, citing the cautious 2026 guidance as the primary driver. The market’s concern centers on the company’s ability to reverse revenue decline, mitigate margin compression, and achieve profitability in a challenging macro environment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.